These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10459572)

  • 21. The effect of methylenetetrahydrofolate reductase C677T common variant on hypertensive risk is not solely explained by increased plasma homocysteine values.
    Rodríguez-Esparragón F; Hernández-Perera O; Rodríguez-Pérez JC; Anábitarte A; Díaz-Cremades JM; Losada A; Fiuza D; Hernández E; Yunis C; Ferrario CM
    Clin Exp Hypertens; 2003 May; 25(4):209-20. PubMed ID: 12797595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism and the B-vitamins: a facet of nature-nurture interplay.
    Herrmann W; Obeid R; Schorr H; Zarzour W; Geisel J
    Clin Chem Lab Med; 2003 Apr; 41(4):547-53. PubMed ID: 12747601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.
    Nakamura T; Saionji K; Hiejima Y; Hirayama H; Tago K; Takano H; Tajiri M; Hayashi K; Kawabata M; Funamizu M; Makita Y; Hata A
    Am J Kidney Dis; 2002 May; 39(5):1032-9. PubMed ID: 11979347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the methylenetetrahydrofolate reductase 677C-->T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample.
    de Bree A; Verschuren WM; Bjørke-Monsen AL; van der Put NM; Heil SG; Trijbels FJ; Blom HJ
    Am J Clin Nutr; 2003 Mar; 77(3):687-93. PubMed ID: 12600862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperhomocysteinemia is related to residual glomerular filtration and folate, but not to methylenetetrahydrofolate-reductase and methionine synthase polymorphisms, in supplemented end-stage renal disease patients undergoing hemodialysis.
    Anwar W; Guéant JL; Abdelmouttaleb I; Adjalla C; Gérard P; Lemoel G; Erraess N; Moutabarrek A; Namour F
    Clin Chem Lab Med; 2001 Aug; 39(8):747-52. PubMed ID: 11592445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocystinemia in normal and thromboembolic subjects.
    Gemmati D; Previati M; Serino ML; Moratelli S; Guerra S; Capitani S; Forini E; Ballerini G; Scapoli GL
    Arterioscler Thromb Vasc Biol; 1999 Jul; 19(7):1761-7. PubMed ID: 10397696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The methylenetetrahydrofolate reductase C677T gene mutation is associated with hyperhomocysteinemia, cardiovascular disease and plasma B-type natriuretic peptide levels in Korea.
    Cho SE; Hong KS; Shin GJ; Chung WS
    Clin Chem Lab Med; 2006; 44(9):1070-5. PubMed ID: 16958597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis.
    Koch HG; Nabel P; Junker R; Auberger K; Schobess R; Homberger A; Linnebank M; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S113-6. PubMed ID: 10650848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The common mutations C677T and A1298C in the human methylenetetrahydrofolate reductase gene are associated with hyperhomocysteinemia and cardiovascular disease in hemodialysis patients.
    Haviv YS; Shpichinetsky V; Goldschmidt N; Atta IA; Ben-Yehuda A; Friedman G
    Nephron; 2002 Sep; 92(1):120-6. PubMed ID: 12187094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylenetetrahydrofolate reductase 677C-->T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial.
    Ashfield-Watt PA; Pullin CH; Whiting JM; Clark ZE; Moat SJ; Newcombe RG; Burr ML; Lewis MJ; Powers HJ; McDowell IF
    Am J Clin Nutr; 2002 Jul; 76(1):180-6. PubMed ID: 12081832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folate status and a new repletion cut-off value in a group of healthy Majorcan women.
    Martín I; Obrador A; Gibert MJ; Hernanz A; Fuster A; Pintos C; Garcia A; Tur J
    Clin Nutr; 2003 Feb; 22(1):53-8. PubMed ID: 12553950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of MTHFR genotypes and hyperhomocysteinemia on patient and graft survival in kidney transplant recipients.
    Hagen W; Födinger M; Heinz G; Buchmayer H; Hörl WH; Sunder-Plassmann G
    Kidney Int Suppl; 2001 Feb; 78():S253-7. PubMed ID: 11169021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis.
    Brattström L; Wilcken DE; Ohrvik J; Brudin L
    Circulation; 1998 Dec; 98(23):2520-6. PubMed ID: 9843457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relation between plasma homocysteine concentration and methylenetetrahydrofolate reductase gene polymorphism in pregnant women.
    Murakami S; Matsubara N; Saitoh M; Miyakaw S; Shoji M; Kubo T
    J Obstet Gynaecol Res; 2001 Dec; 27(6):349-52. PubMed ID: 11794822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5,10-methylenetetrahydrofolate reductase common mutations, folate status and plasma homocysteine in healthy French adults of the Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) cohort.
    Chango A; Potier De Courcy G; Boisson F; Guilland JC; Barbé F; Perrin MO; Christidès JP; Rabhi K; Pfister M; Galan P; Hercberg S; Nicolas JP
    Br J Nutr; 2000 Dec; 84(6):891-6. PubMed ID: 11177206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs.
    Belcastro V; Striano P; Gorgone G; Costa C; Ciampa C; Caccamo D; Pisani LR; Oteri G; Marciani MG; Aguglia U; Striano S; Ientile R; Calabresi P; Pisani F
    Epilepsia; 2010 Feb; 51(2):274-9. PubMed ID: 19780797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma homocysteine, methylenetetrahydrofolate reductase genotypes, and age at onset of symptoms of myocardial ischemia.
    Mager A; Battler A; Birnbaum Y; Magal N; Shohat M
    Am J Cardiol; 2002 Apr; 89(8):919-23. PubMed ID: 11950428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 677C --> T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in epileptic patients affected by systemic lupus erythematosus.
    Afeltra A; Amoroso A; Mitterhofer AP; Vadacca M; Galluzzo S; Francia A; Del Porto F; Gandolfo GM
    Seizure; 2002 Jun; 11(4):250-4. PubMed ID: 12027572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of plasma homocysteine levels and MTHFR polymorphisms on IQ scores in children and young adults with epilepsy treated with antiepileptic drugs.
    Di Rosa G; Lenzo P; Parisi E; Neri M; Guerrera S; Nicotera A; Alibrandi A; Germanò E; Caccamo D; Spanò M; Tortorella G
    Epilepsy Behav; 2013 Dec; 29(3):548-51. PubMed ID: 24183735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homocysteine and the MTHFR 677C-->T allele in premature coronary artery disease. Case control and family studies.
    Pintó X; Vilaseca MA; Garcia-Giralt N; Ferrer I; Palá M; Meco JF; Mainou C; Ordovás JM; Grinberg D; Balcells S;
    Eur J Clin Invest; 2001 Jan; 31(1):24-30. PubMed ID: 11168435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.